SAKAR HEALTHCARE
|
The Current P/E Ratio of SAKAR HEALTHCARE is 37.59.
Share Price | ₹255.1 | Mar 10,2025 |
Market Cap | ₹558.6 Cr | |
Earnings-TTM | ₹14.9 Cr | TTM-Consolidated Results |
Price/Earnings | 37.59x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SAKAR HEALTHCARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹558.6 Cr] as on Mar 10,2025
(/) Earnings [ ₹14.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 37.59x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay 37.59 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAKAR HEALTHCARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SAKAR HEALTHCARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SAKAR HEALTHCARE
PE Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 27.63x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 16.54x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 68.64x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 7.77x.
How does SAKAR HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SAKAR HEALTHCARE | 14.86 | 37.59 | 558.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 34.59 | 397,246.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 71.18 | 147,119.0 |
CIPLA LTD | 5,000.43 | 23.36 | 116,805.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 55.61 | 103,554.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.17 | 93,192.0 |
MANKIND PHARMA LTD | 2,050.73 | 44.47 | 91,196.4 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.72 | 90,551.0 |
LUPIN LTD | 2,892.10 | 31.20 | 90,226.2 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.10 | 63,368.4 |
ABBOTT INDIA LTD | 1,334.46 | 48.58 | 64,826.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAKAR HEALTHCARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.17x |
Max industry PE | 71.18x |
Median industry PE | 34.59x |
Average industry PE | 36.51x |
You may also like the below Video Courses